ChrysCap backs Curatio in latest pharma bet

Mumbai: ChrysCapital will buy a significant minority stake in Curatio Healthcare, an emerging dermatology products maker, marking its tenth investment in the Indian pharmaceutical sector. The country’s largest private equity investor, which has backed several pharma entrepreneurs like Chudgars of Intas and Junejas of Mankind, is investing Rs 130 crore ($20 million) to help the Chennai-based Curatio accelerate growth plans.

Investment bank MAPE has advised on the deal. ChrysCapital said it was backing a combination of a great management team, strong brands and superior marketing capabilities in the fast growing dermatology segment of the Indian pharma market. The annual sales of dermatology products was expanding at 16-18% and stood at Rs 7,000 crore — about 6% of the domestic pharma market estimated at Rs 1.2 lakh crore. Curatio’s main focus is on paediatric cosmetology — where it is building brands like Tedibar, which is poised to be a Rs 50-crore brand.

ChrysCapital VP Kshitij Seth said, “We decided to dig deeper in striking new pharma investments given the sector’s multiple growth challenges right now. We believe Curatio represents a high growth niche business.” Curatio, which counts VC firm Sequoia Capital as an investor, has a field force of 550 employees, reaching over 20,000 doctors across India. The company has started tapping international markets with presence in the Philippines, Sri Lanka and Bangladesh. The founders of erstwhile American Remedies, which was sold to Dr Reddy’s Laboratories, invested behind a set of professionals turned entrepreneurs to start Curatio. Krishna Ramanathan of Fulcrum Ventures, an early investor backing Curatio, said the entry of ChrysCapital would help the company sustain high organic growth and chase acquisition opportunities in the domestic market.

ChrysCapital, which has raised $3.2 billion across seven funds, had earlier backed other pharma companies, including Eris Lifesciences, Zydus Cadila and Torrent Pharma. The private equity firm has reaped $1 billion from investing about $150-200 million in nine pharma companies. Overall, ChrysCapital has returned $5 billion to investors through 65 profitable exits.

  • Related Posts

    CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

    CBI alleges SI Kumar disposed of the bribe amount after the transaction, and it has not been recovered yet. Two sub-inspectors posted with the Narcotics Control Bureau have been arrested…

    Sakeena Itoo reviews functioning of Drug Testing Laboratory, GMC Kathua

    Minister directs quality testing, optimum utilisation of medical infra Kathua: Minister for Health and Medical Education and Social Welfare, Sakeena Itoo, Monday visited the Modern Drug Testing Laboratory and Government…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

    A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

    CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

    CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

    Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested

    Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested

    Sakeena Itoo reviews functioning of Drug Testing Laboratory, GMC Kathua

    Sakeena Itoo reviews functioning of Drug Testing Laboratory, GMC Kathua

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive